AF
DAWN

Allworth Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Allworth Financial’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.5K Buy
1,002
+810
+422% +$11.4K ﹤0.01% 2941
2025
Q4 		$1.79K Buy
192
+66
+52% +$551 ﹤0.01% 4164
2025
Q3 		$889 Sell
126
-4
-3% -$28 ﹤0.01% 4288
2025
Q2 		$845 Buy
130
+107
+465% +$736 ﹤0.01% 4003
2025
Q1 		$182 Buy
23
+17
+283% +$183 ﹤0.01% 3890
2024
Q4 		$75 Hold
6
– – ﹤0.01% 3856
2024
Q3 		$84 Buy
+6
New +$86 ﹤0.01% 3666

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Allworth Financial's DAWN Position: Q1 2026 in Review

Allworth Financial increased its Day One Biopharmaceuticals (DAWN) stake by 422% in Q1 2026, buying an estimated $11.4K and bringing the position to 1,002 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Allworth Financial first reported a position in DAWN in Q3 2024 and has held it in 7 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Allworth Financial held 1,002 shares of Day One Biopharmaceuticals worth $21.5K as of Q1 2026.
  • Allworth Financial bought 810 Day One Biopharmaceuticals shares in Q1 2026, an estimated $11.4K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #2941 holding.
  • Allworth Financial first reported a position in Day One Biopharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.